x

Abivax S.A. (Nasdaq:ABVX)

Health Care/Life Sciences • Pharmaceuticals
CIK 1956827
Company

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Address
7-11 Boulevard Haussmann
Paris, Ile-de-France 75009
Employees
61
Stock Info
Close
$7.85
Day Range
7.33 - 7.95
52 Week Range
5.50 - 17.02
Average volume
161.23K
Short Interest
1.15M (02/14/25)
% of Float Shorted
2.10%
Market Cap
$472.74M
Revenue
N/A
Net Income
-$147.74M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$3.55
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Sylvie Louise Grégoire
Director
June H Lee
Director
Troy A. Ignelzi
Director
Camilla Soenderby
Director
Kinam Hong
Independent Director
Corinna Zur Bonsen-Thomas
SEC filings
DateFormEvent
26 Nov, 2024 EFFECT
19 Nov, 2024 6-K
19 Nov, 2024 F-3
14 Nov, 2024 6-K
14 Nov, 2024 SC 13G/A
3 Oct, 2024 6-K
3 Oct, 2024 6-K
26 Sep, 2024 6-K
25 Sep, 2024 6-K
9 Sep, 2024 6-K
9 Sep, 2024 6-K
6 Aug, 2024 6-K
16 Jul, 2024 6-K
4 Jun, 2024 6-K
7 May, 2024 6-K
19 Apr, 2024 SC 13G
5 Apr, 2024 20-F
2 Apr, 2024 6-K
14 Feb, 2024 SC 13G/A
2 Feb, 2024 6-K
22 Jan, 2024 6-K
22 Nov, 2023 SC 13G
30 Oct, 2023 SC 13G
30 Oct, 2023 SC 13D
23 Oct, 2023 424B4 IPO completed
20 Oct, 2023 SEC STAFF
20 Oct, 2023 FWP
19 Oct, 2023 EFFECT
19 Oct, 2023 CERT
19 Oct, 2023 EFFECT
18 Oct, 2023 F-1/A
18 Oct, 2023 8-A12B
18 Oct, 2023 CORRESP
18 Oct, 2023 CORRESP
18 Oct, 2023 CORRESP
17 Oct, 2023 UPLOAD
16 Oct, 2023 CORRESP
16 Oct, 2023 F-1/A
5 Oct, 2023 UPLOAD
3 Oct, 2023 F-6
29 Sep, 2023 F-1
29 Sep, 2023 CORRESP
20 Sep, 2023 SEC STAFF
20 Sep, 2023 UPLOAD
8 Sep, 2023 DRSLTR
8 Sep, 2023 DRS/A
18 Aug, 2023 UPLOAD
28 Jul, 2023 DRS/A
28 Jul, 2023 DRSLTR
12 Jan, 2023 UPLOAD
16 Dec, 2022 DRS
Last update:2025-03-06 12:16:17.722823
Abivax S.A. by TradingView

Sign Up to Subscribe